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Adult T-cell leukemia/lymphoma (ATLL) is a rare and
aggressive T-cell leukemia/lymphoma that is etiologically
linked to infection by human T-cell lymphotropic virus
type 1 (HTLV-1). To find candidate causative genes
for ATLL development, we used an integrative genomic
analysis of ATLL and identified N-myc downstream-
regulated gene 2 (NDRG2) as a candidate tumour suppres-
sor gene on chromosome 14q11. Here we demonstrate
that NDRG2 is a novel PTEN-interacting protein and
recruits protein phosphatase 2A to facilitate the depho-
sphorylation of PTEN at the Ser380, Thr382, and Thr383
(STT) cluster within the C terminus. Although the PI3K/
AKT signalling pathway is frequently activated in ATLL
cells, neither the genetic alterations of the PTEN and
PIK3CA genes nor the transcriptional down-regulation of
PTEN expression were detected in ATLL. We found
that activation of the PI3K/AKT signalling pathway in
ATLL is mediated through hyperphosphorylation of
PTEN-STT, a well-known mechanism of PTEN inactiva-
tion, by down-regulation of NDRG2 expression. Moreover,
we found that NDRG2 deficiency in mice results in consti-
tutive PI3K/AKT activation in various organs and high
incidence of T-cell lymphoma and other types of cancer.
Since down-regulation of NDRG2 expression via promoter
methylation has been reported in various types of cancer,
activation of the PI3K/AKT pathway by the enhanced
PTEN-STT phosphorylation through the inactivation of
NDRG2 is crucial for the development of a wide range of
cancer cells including ATLL, which harbor no activating
genetic alterations in the PI3K/AKT pathway.
Authors’ details
1Division of Tumor and Cellular Biochemistry, Department of Medical
Sciences, University of Miyazaki, Kiyotake, Miyazaki, Japan. 2Division of Cancer
Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
3Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural
University of Medicine, Kamigyo-ku, Kyoto, Japan. 4Department of Molecular
Hematology and Oncology, Kyoto Prefectural University of Medicine,
Kamigyo-ku, Kyoto, Japan.
Published: 7 January 2014
doi:10.1186/1742-4690-11-S1-P87
Cite this article as: Nakahata et al.: NDRG2 plays a pivotal role in ATLL
leukaemogenesis by regulating the PTEN-mediated PI3K/AKT
signalling pathway. Retrovirology 2014 11(Suppl 1):P87.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: kmorishi@fc.miyazaki-u.ac.jp
1Division of Tumor and Cellular Biochemistry, Department of Medical
Sciences, University of Miyazaki, Kiyotake, Miyazaki, Japan
Full list of author information is available at the end of the article
Nakahata et al. Retrovirology 2014, 11(Suppl 1):P87
http://www.retrovirology.com/content/11/S1/P87
© 2014 Nakahata et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
